Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 May 2002

Randomised, cross-over, placebo controlled trial of magnesium citrate in thetreatment of chronic persistent leg cramps.

Sheila Sills, Christine Roffe, Peter Crome, Peter Jones

Med Sci Monit 2002; 8(5): CR326-330 :: ID: 420841

Abstract

BACKGROUND: Nocturnal leg cramps are common and distressing. The only treatmentof proven effectiveness is quinine, but this has a number of side effects. Magnesium salts have beenshown to reduce leg cramp distress in pregnancy. This study tests whether magnesium citrate is effectivein the treatment of leg cramps in non-pregnant individuals by conducting in a randomised, double-blind,cross-over placebo-controlled trial. MATERIAL/METHODS: Volunteers suffering regular leg cramps were recruited.Magnesium citrate equivalent to 300 mg magnesium and matching placebo were given for 6 weeks each. Thenumber of cramps recorded in the cramp diary during the final 4 weeks of magnesium and placebo treatment,severity and duration of cramps and the participants' subjective assessment of effectiveness were analysed.RESULTS: In subjects who started with placebo (n=29) the median (95% CI) number of cramps was 9 (6-17)on placebo and 5 (4-8) on magnesium. For the group starting with magnesium (n=17) the median no of crampswas 9 (5-13) on magnesium and 8 (4-14) on placebo. There was no significant carry-over effect (p=0.88),but a highly significant period effect (p=0.008). There was a trend towards less cramps on magnesium(p=0.07). There was no difference in cramp severity and duration between the groups. Significantly moresubjects thought that the treatment had helped after magnesium than after placebo 36 (78%) and 25 (54%)respectively, (p=0.03). Diarrhoea was recorded as a side effect of magnesium. CONCLUSIONS: The resultssuggest that magnesium may be effective in treatment of nocturnal leg cramps. Further evaluation is recommended.

Keywords: Cathartics, Citric Acid, Cross-Over Studies, Double-Blind Method, Muscle Cramp, Organometallic Compounds, Placebos, Research Support, Non-U.S. Gov, Sleep Disorders, Time Factors, Trace Elements

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750